Tetrasomy 21 as a sole acquired abnormality without GATA1 gene mutation in pediatric acute megakaryoblastic leukemia: A case report and review of the literature

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1615-1619

  Shin, Myung Geun ^a   Choi, Hyun Woo ^a   Kim, Hye Ran ^a,b   Kim, Mi Ji ^a   Baek, Hee Jo ^a   Han, Dong Kyun ^a   Kook, Hoon ^a   Hwang, Tai Ju ^a   Kim, Hyoung Joon ^a   Kim, Soo Hyun ^a   Shin, Jong Hee ^a   Suh, Soon Pal ^a   Ryang, Dong Wook ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Acute megakaryoblastic leukemia; GATA1; Tetrasomy 21

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD61 ANTIGEN; CD7 ANTIGEN; FIBRINOGEN RECEPTOR; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR RUNX1;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE MARROW CELL; CASE REPORT; CELL INFILTRATION; CHILDHOOD CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOPHENOTYPING; INTERPHASE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TETRASOMY; TETRASOMY 21;

ANEUPLOIDY; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CYTOGENETIC ANALYSIS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HUMANS; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MUTATION;

EID: 44749093964     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.02.010     Document Type: Article

References (31)

1. Haase D., Fonatsch C., Freund M., Wormann B., Bodenstein H., Bartels H., et al. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 70 (1995) 171-187
2. Cortes J.E., Kantarjian H., O'Brien S., Keating M., Pierce S., Freireich E.J., et al. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia 9 (1995) 115-117
3. Raimondi S.C., Pui C.H., Hancock M.L., Behm F.G., Filatov L., and Rivera G.K. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10 (1996) 213-224
4. Wei C.H., Yu I.T., Tzeng C.H., Fan F.S., Hsieh R.K., Chiou T.J., et al. Trisomy 21 in acute myeloid leukemia. Cancer Genet Cytogenet 86 (1996) 177-180
5. Slavc I., Urban C., Haas O.A., Kroisel P.M., and Koller U. Acute megakaryocytic leukemia in children. Clinical, immunologic, and cytogenetic findings in two patients. Cancer 68 (1991) 2266-2272
6. Rogan P.K., Close P., Blouin J.-L., Seip J.R., Gannutz L., Ladda R.L., et al. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia. Am J Med Genet 59 (1995) 174-181
7. Mitelman F., Mertens F., and Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15 (1997) 417-474
8. Groupe Francais de Cytogenetique Hematologique. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Cancer Genet Cytogenet 1988;32:157-68.
9. Takeda T., Murano K., Chihara H., Taki M., Watanabe A., Yamada K., et al. Transient myeloproliferative disorder (TMD) with transiently increased tetrasomy-21 cells in a phenotypically normal newborn. Jpn J Clin Hematol 30 (1989) 1010-1015
10. Dewald G.W., Diez-Martin J.L., Steffen S.L., Jenkins R.B., Stupca P.J., and Burgert E.O. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome. Am J Med Genet Suppl 7 (1990) 247-250
11. Mori P.G., Haupt R., Fugazza G., Sessarego M., Corcione A., Strigini P., et al. Pentasomy 21 in leukemia complication Diamond-Blackfan anemia. Cancer Genet Cytogenet 63 (1992) 70-72
12. Potocki L., Townes P.L., Woda B.A., Rao S.K., Shearin J.P., and Schwenn M.R. Tetrasomy 21 in megakaryoblastic leukaemia. Cancer Genet Cytogenet 74 (1994) 66-70
13. Udayakumar A.M., and Sundareshan T.S. Tetrasomy 21 as a sole abnormality in erythroleukemia. Cancer Genet Cytogenet 85 (1995) 85-87
14. Hasle H., Olesen G., Kerndrup G., Philip P., and Jacobsen N. Chronic neutrophil leukaemia in adolescence and young adulthood. Br J Haematol 94 (1996) 628-630
15. Wan T.S.K., Au W.Y., Chan J.C.W., Chan L.C., and Ma S.K. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid anemia and myelodysplastic syndrome. Leuk Res 23 (1999) 1079-1083
16. Preudhomme C., Warot-Loze D., Roumier C., Grardel-Duflos N., Garand R., Lai J.L., et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2B gene in M0 acute leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96 (2000) 2862-2869
17. Odagaki T., Sugimoto T., Matsuo M., Tatsumi E., and Saigo K. Tetrasomy 21 as the sole acquired karyotypic abnormality in acute myeloblastic leukemia. Cancer Genet Cytogenet 128 (2001) 158-160
18. Ohsaka A., Hisa T., Watanabe N., Kojima H., and Nagasawa T. Tetrasomy 21 as a sole chromosome abnormality in acute myeloid leukemia: fluorescence in situ hybridization and spectral karyotyping analyses. Cancer Genet Cytogenet 134 (2002) 60-64
19. Sandoval C., Pine S.R., Guo Q., Sastry S., Stewart J., Kronn D., et al. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature. Pediatr Blood Cancer 44 (2005) 85-91
20. Shaffer L.G., and Tommerup N. ISCN 2005: an International System for Human Cytogenetic Nomenclature (2005), S. Karger, Basel
21. Brunning R.D., Matutes E., Flandrin G., and Vardiman J. Acute myeloid leukemia not otherwise categorised. In: Vardiman J.W. (Ed). Pathology and genetics of tumours of the haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 106-107
22. Gamis A.S., and Hilden J.M. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?. J Pediatr Hematol Oncol 24 (2002) 2-5
23. Cantor A.B., and Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21 (2002) 3368-3376
24. Orkin S.H., Shivdasani R.A., Fujiwara Y., and McDevitt M.A. Transcription factor GATA-1 in megakaryocyte development. Stem Cells 16 (1998) 79-83
25. Shivdasani R.A. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 19 (2001) 397-407
26. Weschler J., Greene M., McDevitt M.A., Anastasi J., Karp J.E., Le Beau M.M., et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 32 (2002) 148-152
27. Mundschau G., Gurbuxani S., Gamis A.S., Greene M.E., Arceci R.J., and Crispino J.D. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 101 (2003) 4298-4300
28. Rainis L., Bercovich D., Strehl S., Schlegel A.T., Stark B., Trka J., et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102 (2003) 981-986
29. Minelli A., Morerio C., Maserati E., Olivieri C., Panarello C., Bonvini L., et al. Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia. Leukemia 15 (2001) 971-975
30. Xue Y., Guo Y., Zhou Y., Xie X., Zheng L., and Shen M. Isolated tetrasomy 8 in minimally differentiated acute myeloid leukemia (AML-M0). Leuk Lymphoma 33 (1999) 581-585
31. Onodera N., McCabe N.R., and Rubin C.M. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 80 (1992) 203-208